206 related articles for article (PubMed ID: 29915885)
1. Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images.
Reinert CP; Hinterleitner C; Fritz J; Nikolaou K; Horger M
Eur Radiol; 2019 Jan; 29(1):450-457. PubMed ID: 29915885
[TBL] [Abstract][Full Text] [Related]
2. Discriminatory CT-textural features in splenic infiltration of lymphoma versus splenomegaly in liver cirrhosis versus normal spleens in controls and evaluation of their role for longitudinal lymphoma monitoring.
Reinert CP; Kloth C; Fritz J; Nikolaou K; Horger M
Eur J Radiol; 2018 Jul; 104():129-135. PubMed ID: 29857858
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of whole-body MRI in the assessment of splenic involvement in lymphoma.
Littooij AS; Kwee TC; Barber I; Granata C; de Keizer B; Beek FJ; Hobbelink MG; Fijnheer R; Stoker J; Nievelstein RA
Acta Radiol; 2016 Feb; 57(2):142-51. PubMed ID: 25681490
[TBL] [Abstract][Full Text] [Related]
4. Assessment of splenic perfusion in patients with malignant hematologic diseases and spleen involvement, liver cirrhosis and controls using volume perfusion CT (VPCT): a pilot study.
Sauter AW; Feldmann S; Spira D; Schulze M; Klotz E; Vogel W; Claussen CD; Horger MS
Acad Radiol; 2012 May; 19(5):579-87. PubMed ID: 22326669
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in splenic marginal zone lymphoma.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
[TBL] [Abstract][Full Text] [Related]
6. Imaging of the spleen: CT with supplemental MR examination.
Rabushka LS; Kawashima A; Fishman EK
Radiographics; 1994 Mar; 14(2):307-32. PubMed ID: 8190956
[TBL] [Abstract][Full Text] [Related]
7. Comparison of volume and attenuation of the spleen between postmortem and antemortem computed tomography.
Okuma H; Gonoi W; Ishida M; Shirota G; Kanno S; Shintani Y; Abe H; Fukayama M; Ohtomo K
Int J Legal Med; 2016 Jul; 130(4):1081-1087. PubMed ID: 26914802
[TBL] [Abstract][Full Text] [Related]
8. Explanations for the heterogeneity of splenic enhancement derived from blood flow kinetic measurements using dynamic contrast-enhanced CT (DCE-CT).
Sauter AW; Spira D; Schulze M; Horger MS
Acta Radiol; 2014 Jul; 55(6):645-53. PubMed ID: 24005563
[TBL] [Abstract][Full Text] [Related]
9. Spleen in haematological malignancies: spectrum of imaging findings.
Saboo SS; Krajewski KM; O'Regan KN; Giardino A; Brown JR; Ramaiya N; Jagannathan JP
Br J Radiol; 2012 Jan; 85(1009):81-92. PubMed ID: 22096219
[TBL] [Abstract][Full Text] [Related]
10. Detection of Moderate Hepatic Steatosis on Portal Venous Phase Contrast-Enhanced CT: Evaluation Using an Automated Artificial Intelligence Tool.
Pickhardt PJ; Blake GM; Kimmel Y; Weinstock E; Shaanan K; Hassid S; Abbas A; Fox MA
AJR Am J Roentgenol; 2023 Dec; 221(6):748-758. PubMed ID: 37466185
[No Abstract] [Full Text] [Related]
11. Diffuse Infiltrative Splenic Lymphoma: Diagnostic Efficacy of Arterial-Phase CT.
Lee JE; Cho JS; Shin KS; Kim SS; You SK; Park JW; Shin HS; Yoon YC
Korean J Radiol; 2016; 17(5):734-41. PubMed ID: 27587962
[TBL] [Abstract][Full Text] [Related]
12. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
Karunanithi S; Sharma P; Roy SG; Vettiyil B; Sharma A; Thulkar S; Bal C; Kumar R
Clin Nucl Med; 2014 Sep; 39(9):772-6. PubMed ID: 25036015
[TBL] [Abstract][Full Text] [Related]
13. Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?
Vera P; Ouvrier MJ; Hapdey S; Thillays M; Pesquet AS; Diologent B; Callonec F; Hitzel A; Edet-Sanson A; Ménard JF; Jardin F; Tilly H
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1943-52. PubMed ID: 17694309
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma.
Rini JN; Leonidas JC; Tomas MB; Palestro CJ
J Nucl Med; 2003 Jul; 44(7):1072-4. PubMed ID: 12843223
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study.
Picardi M; Soricelli A; Pane F; Zeppa P; Nicolai E; De Laurentiis M; Grimaldi F; Rotoli B
Radiology; 2009 May; 251(2):574-82. PubMed ID: 19401581
[TBL] [Abstract][Full Text] [Related]
16. Qualitative assessment of liver for fatty infiltration on contrast-enhanced CT: is muscle a better standard of reference than spleen?
Panicek DM; Giess CS; Schwartz LH
J Comput Assist Tomogr; 1997; 21(5):699-705. PubMed ID: 9294555
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic CT of lymphoma manifestations of the liver and spleen].
Kurtz B
Rofo; 1986 Feb; 144(2):149-53. PubMed ID: 3006164
[TBL] [Abstract][Full Text] [Related]
18. CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma.
de Jong PA; van Ufford HM; Baarslag HJ; de Haas MJ; Wittebol SH; Quekel LG; de Klerk JM
AJR Am J Roentgenol; 2009 Mar; 192(3):745-53. PubMed ID: 19234273
[TBL] [Abstract][Full Text] [Related]
19. Post-contrast CT liver attenuation alone is superior to the liver-spleen difference for identifying moderate hepatic steatosis.
Pickhardt PJ; Blake GM; Moeller A; Garrett JW; Summers RM
Eur Radiol; 2024 Jun; ():. PubMed ID: 38834787
[TBL] [Abstract][Full Text] [Related]
20. Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations.
Jawahar A; Gonzalez B; Balasubramanian N; Adams W; Goldberg A
Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1389-1396. PubMed ID: 28957871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
